Study Finds Inadequate Use of Recommended Combination Treatment for Miscarriage in the U.S.

A new study published in the Journal of the American Medical Association by researchers at Vanderbilt University Medical Center has found that the recommended two-medication regimen, mifepristone plus misoprostol (similar to that used for induced medication abortion) remains significantly underused despite recommendations to do so from medical professionals

Lesley Tomaszewski, PhD, MS

Lesley
Tomaszewski
PhD, MS
Adjunct Professor
Health Policy

Dr. Lesley Tomaszewski is an Associate Professor and the Director of Healthcare Programs at Lipscomb University. Since graduating with her PhD in 2003, Dr. Tomaszewski has taught in American and Dutch universities and worked on several National Science Foundation (NSF) research grants.Tomaszewski's research interests include leadership development and employee engagement within health care. She is an experienced qualitative researcher with over 20 years of experience in the United States and abroad. Prior to coming to Lipscomb in August 2021, Dr. Tomaszewski was the MHA Deputy Director and an Associate Professor (non-tenure) at Texas A&M University.

Nashville
Tennessee
letomaszewski@lipscomb.edu

Jessica S. Ancker, PhD, MPH, FACMI

Jessica
S
Ancker
PhD, MPH, FACMI
Professor (secondary appointment)
Department of Health Policy, Vanderbilt University Medical Center
Professor
Departments of Biomedical Informatics, Vanderbilt University Medical Center
Professor
Department of Health Policy
Vice Chair for Educational Affairs
Department of Biomedical Informatics, Vanderbilt University Medical Center

https://www.vumc.org/dbmi/person/jessica-s-ancker-phd-mph-facmi

Dr. Ancker is a Professor of biomedical informatics who has worked in several different areas of healthcare and health policy. She has been a part of several grant review boards and serves as an associate editor for the Journal of the American Medical Informatics Association and Medical Decision Making and MDM Policy & Practice. She has also worked in different roles in institutional committees and centers at both Cornell University and Vanderbilt University. Her research interests focus on biomedical informatics, health services research, health literacy and numeracy, telemedicine, and optimal health for all.

 

She is also the Vice-Chair for Educational Affairs of the Department of Biomedical Informatics.

Phone
(646) 248 9281
2525 West End Ave., Rm 14122
Room / Suite
14122
Nashville
Tennessee
37203
jessica.s.ancker@vanderbilt.edu

Pair of new research papers highlights variation, benefit of opioid treatment programs

Two new research papers published in the journal Medical Care led by Vanderbilt University Medical Center faculty highlight two different areas related to opioid use treatment in women of reproductive age across several U.S. states. Both studies used similar data and study designs from a randomized field experiment where nearly 4,000 trained callers, either on public health insurance (Medicaid) or private insurance, attempted to seek appointments for treating opioid use disorder across 10 states in the U.S.

Maternal OUD and NOWS increases risk of postneonatal infant mortality

In a new study led by Vanderbilt University Medical Center researchers, infants born to individuals who had opioid use disorder (OUD) during pregnancy or who developed neonatal opioid withdrawal syndrome (NOWS) faced a 54-64% greater risk of postneonatal death than infants without these exposures.

Dawn Schwartz, MA

Dawn
Schwartz
Project Manager
Health Policy
Phone
615-936-8984
Office Address
2525 West End Ave., Suite 1200
Suite 1200
Room / Suite
1200
Nashville
Tennessee
37203
dawn.schwartz@vumc.org

Dustin Jackson

Dustin
Jackson
Budget/Accounting Analyst
Health Policy
2525 West End Ave.
Suite 1275
Room / Suite
1275
Nashville
Tennessee
37203
dustin.jackson@vumc.org

Hank Vest

Hank
Vest
Program Manager
Health Policy
Office Address
2525 West End Ave.
Suite 700
Room / Suite
700
Nashville
Tennessee
37203
hank.vest@vumc.org